Get LB Pharmaceuticals alerts:ProfitabilityThis table compares LB Pharmaceuticals and its peers’ net margins, return on equity and return on assets. Net Margins Return on Equity Return on Assets LB Pharmaceuticals N/A N/A N/A LB Pharmaceuticals Competitors -2,478.03% -250.55% -16.90%Analyst RatingsSell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score LB Pharmaceuticals 1 1 6 2 2.90 LB Pharmaceuticals Competitors 7594 13671 25498 988 2.42This is a summary of recent recommendations and price targets for LB Pharmaceuticals and its peers, as reported by MarketBeat. Given LB Pharmaceuticals’ peers higher possible upside, analysts plainly believe LB Pharmaceuticals has less favorable growth aspects than its peers. Gross Revenue Net Income Price/Earnings Ratio LB Pharmaceuticals N/A -$25.20 million -24.76 LB Pharmaceuticals Competitors $3.50 billion $3.11 billion 510.25LB Pharmaceuticals’ peers have higher revenue and earnings than LB Pharmaceuticals. Receive News & Ratings for LB Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LB Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.